66 related articles for article (PubMed ID: 38442793)
1. Colorectal Cancer: Genetic Underpinning and Molecular Therapeutics for Precision Medicine.
Dosunmu GT; Shergill A
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790167
[TBL] [Abstract][Full Text] [Related]
2. Targeting angiogenesis in gastrointestinal tumors: current challenges.
Nandikolla AG; Rajdev L
Transl Gastroenterol Hepatol; 2016; 1():67. PubMed ID: 28138633
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of metastatic colorectal cancer.
CaƱellas-Socias A; Sancho E; Batlle E
Nat Rev Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38806657
[TBL] [Abstract][Full Text] [Related]
4. Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
Ross JS; Fakih M; Ali SM; Elvin JA; Schrock AB; Suh J; Vergilio JA; Ramkissoon S; Severson E; Daniel S; Fabrizio D; Frampton G; Sun J; Miller VA; Stephens PJ; Gay LM
Cancer; 2018 Apr; 124(7):1358-1373. PubMed ID: 29338072
[TBL] [Abstract][Full Text] [Related]
5. Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.
Meric-Bernstam F; Hurwitz H; Raghav KPS; McWilliams RR; Fakih M; VanderWalde A; Swanton C; Kurzrock R; Burris H; Sweeney C; Bose R; Spigel DR; Beattie MS; Blotner S; Stone A; Schulze K; Cuchelkar V; Hainsworth J
Lancet Oncol; 2019 Apr; 20(4):518-530. PubMed ID: 30857956
[TBL] [Abstract][Full Text] [Related]
6. HER2 targeted therapy in colorectal Cancer: Current landscape and future directions.
Chen N; He L; Zou Q; Deng H
Biochem Pharmacol; 2024 May; 223():116101. PubMed ID: 38442793
[TBL] [Abstract][Full Text] [Related]
7. HER2-targeted therapy: an emerging strategy in advanced colorectal cancer.
La Salvia A; Lopez-Gomez V; Garcia-Carbonero R
Expert Opin Investig Drugs; 2019 Jan; 28(1):29-38. PubMed ID: 30513002
[TBL] [Abstract][Full Text] [Related]
8. Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer.
Siena S; Sartore-Bianchi A; Marsoni S; Hurwitz HI; McCall SJ; Penault-Llorca F; Srock S; Bardelli A; Trusolino L
Ann Oncol; 2018 May; 29(5):1108-1119. PubMed ID: 29659677
[TBL] [Abstract][Full Text] [Related]
9. HER2 as a Predictive Biomarker and Treatment Target in Colorectal Cancer.
De Cuyper A; Van Den Eynde M; Machiels JP
Clin Colorectal Cancer; 2020 Jun; 19(2):65-72. PubMed ID: 32229076
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]